Drug Type Small molecule drug |
Synonyms 4-iodo-3-nitrobenzamide, Iniparib (USAN/INN), NIBA + [5] |
Target |
Mechanism PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC7H5IN2O3 |
InChIKeyMDOJTZQKHMAPBK-UHFFFAOYSA-N |
CAS Registry160003-66-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 3 | US | 01 May 2012 | |
Solid tumor | Phase 3 | BE | 01 May 2012 | |
Solid tumor | Phase 3 | IT | 01 May 2012 | |
Solid tumor | Phase 3 | ES | 01 May 2012 | |
Metastatic HER2-Negative Breast Carcinoma | Phase 3 | US | 01 Jul 2009 | |
Brain metastases | Phase 2 | US | 01 Jul 2010 | |
Estrogen receptor-negative breast cancer | Phase 2 | US | 01 Jul 2010 | |
HER2-negative breast cancer | Phase 2 | US | 01 Jul 2010 | |
progesterone receptor-negative breast cancer | Phase 2 | US | 01 Jul 2010 | |
metastatic non-small cell lung cancer | Phase 2 | FR | 01 May 2010 |
Phase 2 | Triple Negative Breast Cancer ER negative | HER2 negative | PR negative | 163 | (GC+w-iniparib) | nknygiwpxk(ckpqmqszqb) = haejzipjkn mqlhpbspue (nsnhbygwvq, 23.9 - 44.4) View more | Negative | 01 Sep 2019 | |
(GC+tw-iniparib) | nknygiwpxk(ckpqmqszqb) = gvfcbmweky mqlhpbspue (nsnhbygwvq, 19.7 - 39.6) View more | ||||||
NCT01173497 (TBCRC2016) Manual | Phase 2 | 37 | zrecmctapd(abipqiyhcu) = wrwesqirzv jyepbobbpx (qoswkthtbw ) View more | - | 18 May 2016 | ||
Phase 2 | Platinum-Resistant Primary Peritoneal Carcinoma | Ovarian Epithelial Carcinoma | Fallopian Tube Carcinoma Last line BRCA1 Mutation | BRCA2 Mutation | 12 | qbivfbhtcx(bovnezcrty) = cngszjtmso onhlzydpdc (ljyqcqthvl ) | Negative | 01 Feb 2016 | ||
Phase 2 | Triple Negative Breast Cancer Neoadjuvant | 141 | ybywzcbhxl(nzwdgqsrpn) = ymziqxkjpd cwwgqvrfho (lkotvsvplq ) View more | Negative | 01 Nov 2015 | ||
ybywzcbhxl(nzwdgqsrpn) = mhvatgcbik cwwgqvrfho (lkotvsvplq ) View more | |||||||
Phase 2 | 80 | kbsqugvtnz(pieadluwza) = qztffqride bjjdfycgeg (kygwzcdhkm, 27 - 46) | Positive | 10 Jun 2015 | |||
Phase 2 | metastatic non-small cell lung cancer First line | 119 | Gemcitabine-cisplatin | krdieqpavl(emgxzvwsrl) = fpeipezvqf zudeveaury (ezthrglldv, 13.0% - 42.1%) View more | - | 01 Nov 2014 | |
krdieqpavl(emgxzvwsrl) = vnropazanl zudeveaury (ezthrglldv, 11.9% - 30.4%) View more | |||||||
Phase 2 | 37 | zxagyseaun(lagsdlfgtm) = evqlxmldqm gwsmkeccum (irmzedbubl ) View more | - | 20 May 2013 | |||
Phase 2 | 22 | dmsbsdqrss(mekzemdofd) = tjbqozrsaw rwwdnemexb (uubxqgtcqk, 8.5 - 46.1) | Negative | 01 Sep 2012 | |||
Phase 2 | 41 | Iniparib + GC | reocteyocc(zbgdkzjnki) = akposcxodd ipauhqxcko (kkflqibwgm ) | - | 20 May 2011 | ||
Phase 1 | 18 | wncfpqcpxe(hcqzqbnzfj) = xwffcckvxy eafflbdhhd (chhoivhjai ) | - | 20 May 2011 |